Dopamine D 1 and D 2 receptor family contributions to modafinil-induced wakefulness

Journal of Neuroscience

Volumn 29, Issue 9, 2009, Pages 2663-2665

  Young, Jared W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMIC ACID; HISTAMINE; MODAFINIL; NORADRENALIN TRANSPORTER; RACLOPRIDE; SEROTONIN; VANOXERINE; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD LEVEL; BRAIN CORTEX; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RELEASE; DRUG SAFETY; DRUG TARGETING; DYSKINESIA; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; HUMAN; IN VITRO SELECTION; IN VIVO STUDY; LOCOMOTION; LOW DRUG DOSE; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FAMILY; PSYCHOSIS; REM SLEEP; SCHIZOPHRENIA; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SOMNOLENCE; TRAPEZIUS MUSCLE; WAKEFULNESS; WITHDRAWAL SYNDROME; ANIMAL; DOSE RESPONSE; GENETICS; MOUSE; NOTE; SLEEP;

ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SLEEP; SLEEP, REM; WAKEFULNESS;

EID: 63849115108     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5843-08.2009     Document Type: Article

References (13)

1. 5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23:8506-8512.
2. Cohen C, Perrault G, Sanger DJ (1997) Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice. Neuropharmacology 36:1099-1108.
3. Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148-156.
4. Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA (2007) Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. Neuropharmacology 52:626-633.
5. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319:561-569.
6. Mignot E, Nishino S, Guilleminault C, Dement WC (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17:436-437.
7. Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477-1502.
8. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M (1993) Differential effects of dopamine D-1 and D-2 receptor antagonist anti-psychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266:726-731.
9. 2 receptors are essential for the arousal effect of modafinil. J Neurosci 28:8462-8469.
10. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
11. 3 receptors in the human brain. J Neurosci 28:8454-8461.
12. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1787-1794.
13. Wu P, Jones S, Ryan CJ, Michail D, Robinson TD (2008) Modafinil-induced psychosis. Intern Med J 38:677-678.